<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/19A2A787-2FDB-4397-9885-403B7C582232"><gtr:id>19A2A787-2FDB-4397-9885-403B7C582232</gtr:id><gtr:name>Leiden University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4FD9FB9B-1AC9-4050-82D3-05A2614B3733"><gtr:id>4FD9FB9B-1AC9-4050-82D3-05A2614B3733</gtr:id><gtr:firstName>Kevin</gtr:firstName><gtr:surname>Couper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900487"><gtr:id>0AA82CE8-ABA6-42C1-8494-EABB3CB90661</gtr:id><gtr:title>Defining the parasitological and immunological basis of cerebral pathology during murine experimental cerebral malaria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0900487</gtr:grantReference><gtr:abstractText>Cerebral malaria (CM) is a severe complication of some human malaria infections. CM is believed to be caused by the sticking (sequestration) of malaria-infected red blood cells and/or specific types of immune cells (white blood cells) in the small blood vessels of the brain. These blood vessels become clogged, blood flow is reduced and the lack of oxygen and other nutrients causes the patient to go into a coma or to have fits. 

In order to prevent or treat cases of CM, we need a better understanding of the cellular and molecular processes that lead to sequestration of red and white blood cells in the brain. It is impossible to carry out these studies in human malaria patients, but a clinically similar syndrome (experimental CM; ECM) develops in mice infected with particular strains of rodent malaria parasites. Even so, until now, it has been impossible to visualise the key events leading up to ECM in an intact mouse brain. 

I propose to use novel microscopic imaging techniques to visualise the migration, localisation and consequences of parasite and immune cell sequestration in the brains of infected mice and to identify the key molecules and cells involved in development of ECM.</gtr:abstractText><gtr:technicalSummary>Cerebral pathology (CM) is a life-threatening consequence of human Plasmodium falciparum infection and a comparable syndrome (experimental CM; ECM) is seen in susceptible strains of mice infected with P. berghei ANKA. Cerebral accumulation of both parasitised erythrocytes (iRBC) and leucocytes has been implicated in the initiation of CM and ECM, but the sequence of events and the relative importance of these two cell types remains unclear. The advent of new tools for high resolution tracking of individual live cells gives us an opportunity, for the first time, to definitively address these shortfalls in our knowledge. I will use dynamic multi-photon imaging of living brains and thick brain sections of malaria-infected mice, combined with transgenic fluorescently-tagged parasites and various fluorescently-tagged leucocyte populations, to examine the intracerebral migration and localisation of iRBC and leucocytes, enabling the elucidation of the cellular and molecular events that direct these pathological events. Intracerebral parasitic accumulation patterns and leucocyte migration and function will be compared during P. berghei ANKA (ECM causing) infection of C57BL/6 (ECM susceptible) and BALB/c (ECM resistant) mice and with P. berghei NK65 (non-ECM promoting parasite strain) infection of C57BL/6 mice to define the basis of cerebral pathology. 

By integrating imaging techniques with standard immunological approaches (e.g. cell depletion, flow cytometry and real-time PCR) I will determine the phenotype and function of brain infiltrating leucocytes; determining whether specific leucocyte populations (e.g. CD4+ and CD8+ T cells, monocytes) migrate to, and exert effector functions in, specific areas of the brain; and whether this correlates with sites of iRBC sequestration and/or with sites of brain pathology (haemorrhage, oedema, endothelial damage). I will examine whether these responses (homing, sequestration and cytokine production) change during secondary P. berghei ANKA infections (utilising a drug-cure infection model), to investigate the generation of immunological memory to infection and how this alters susceptibility or resistance to ECM. 

Finally, I will determine whether the leucocyte populations that localise in the brain and contribute to development of ECM differ from the leucocytes that are required to control parasite replication and eliminate the infection. For example, pathogenic lymphocytes may differ from protective populations in their effector function (production of cytokines, lytic molecules, superoxides etc), tissue homing (chemokine receptor expression) or regulation (regulatory receptor expression). Putative biomarkers of protective or pathogenic leucocyte populations will be validated using relevant transgenic or gene knock-out mice.</gtr:technicalSummary><gtr:fund><gtr:end>2014-12-11</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1962389</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Immunology and Infection Research</gtr:department><gtr:description>Generation of transgenic Plasmodium berghei parasites</gtr:description><gtr:id>B13E4797-5C58-417A-9E27-AB7B1D0E6E12</gtr:id><gtr:impact>Transgenic P. berghei ANKA parasites optimised for 2 photon imaging:
P. berghei ANKA-mCherry
P. berghei ANKA-TagRFP
P. berghei ANKA-mKate

Collaborators provide molecular parasitology expertise to develop the parasites for use in immunological and parasitological studies.</gtr:impact><gtr:outcomeId>CGjsBq7WrjQ-1</gtr:outcomeId><gtr:partnerContribution>Inserted targeting vectors into parasites</gtr:partnerContribution><gtr:piContribution>Generated targeting vectors for insertion in Plasmodium berghei ANKA parasites</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leiden University Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Generation of transgenic parasites</gtr:description><gtr:id>A3AE704E-3D96-4296-81EC-E3D0E0224D26</gtr:id><gtr:impact>Manuscripts are still in preparation.

3 lines of OVA expressing Plasmodium berghei ANKA and 3 lines of OVA expressing Plasmodium berghei NK65</gtr:impact><gtr:outcomeId>CyQ9sisK7eF-1</gtr:outcomeId><gtr:partnerContribution>Generated he trasngenic OVA-expressing Plasmodium berghei NK65 parasites by reverse purifying existing plasmids from transgenic parasites. 

Expanded upon the original collaboration and generated oher transgenic parasite lines where the OVA is inserted under diffeent promoters.</gtr:partnerContribution><gtr:piContribution>Instigated the collaboration to make the transgenic malaria parasites. Tested and validated the developed parasites.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Computer Science</gtr:department><gtr:description>Modelling of T cell behaviour in the brain</gtr:description><gtr:id>6890C45D-C60B-46DD-9EE0-432D9DD1212E</gtr:id><gtr:impact>Collaboration only recently established</gtr:impact><gtr:outcomeId>YDqhG99ZfYs-1</gtr:outcomeId><gtr:partnerContribution>Applied mathematical modelling to the complex data sets to allow us to better understand T cell tafficking and behaviour in the brain of malaria infected mice</gtr:partnerContribution><gtr:piContribution>Generated the data to be modelled</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>research grant</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6C4066A4-A1B0-4582-9B2A-4F54D376307D</gtr:id><gtr:outcomeId>Udb7uwpTLZw</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Award</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A597A772-42F6-47AE-9B5E-77788A49304C</gtr:id><gtr:outcomeId>mewKQDU9KzV</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>485704</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>New Investigator Project Grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>BBF0A7D8-CFE2-408A-B951-2BD160EA754E</gtr:id><gtr:outcomeId>D6C6kDSyE2A0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Whole genome mouse microrray datasets examining differential gene expression in brains of 4 groups of mice experiencing: 
1. Primary infection with Plasmodium berghei ANKA. Mice have late-stage experimental cerebral malaria (day 7 of infection); 
2. 4th infection (repeated exposure-induced resistance model). Mice are resistant to experimental cerebral malaria (day 7 of 4th infection); 
3. uninfected but age matched; 
4. Mice that have experienced 3 rounds of infection-drug cure but are currently uninfected (30 days after clearance of parasites after 3rd infection).</gtr:description><gtr:id>B27DA487-11BA-4B41-958D-C8BAA67FDF7F</gtr:id><gtr:impact>We have used these datasets to examine the molecular basis of parasite-exposure induced resistance to experimental cerebral malaria. The datasets will be deposited and shared with investigators when the work is published</gtr:impact><gtr:outcomeId>54608aec5dd2c2.26580952</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Exposure-induced resistance microarray database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Whole brain RNA-seq datasets from mice pre and post-drug treatment of cerebral malaria, identifying the transcriptomic changes enforced in the brain following drug treamtent and assessing the temporal recovery of the brain following treatment of the condition. The database can be used to identify new adjunct treatments for the condition</gtr:description><gtr:id>B5B154CC-EB16-476B-AC47-CE51FA96E26D</gtr:id><gtr:impact>None yet but validation of predicted targets for adjunct treatments is ongoing</gtr:impact><gtr:outcomeId>56cb1b42eadd78.11529113</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cerebral malaria drug cure whole brain RNA-seq database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>P. berghei NK65 parasite genetically engineered to express an episomal plasmid (maintained under drug selection pressure) that expresses OVA. Useful for following surrogate parasite specific T cell immune responses</gtr:description><gtr:id>D1DA6B7C-443D-4EB7-B1F8-87F2BA843D44</gtr:id><gtr:impact>Manuscript in preparation.</gtr:impact><gtr:outcomeId>NteHn53tCof</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>P. berghei NK65-OVA plasmid</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic P. berghei ANKA parasites where the fluorescent far red optimised reporter mKateS158 was inserted into the parasite genome under the EF-1alpha promoter</gtr:description><gtr:id>51423142-6AAB-462B-A9B3-91C319FB7610</gtr:id><gtr:impact>The far red (excitation &amp;gt;1000nm) reporter parasites has enabled us to image and locate parasite deeper within tissues. The red shift of the parasites allows multiple colour imaging to visualise multiple processes/events simultaneously.</gtr:impact><gtr:outcomeId>pwSgtVMJN3v</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>P. berghei ANKA mKateS158</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>P. berghei ANKA parasites were transfected with the far red optimized reporter TagRFP, which was inserted under the EF-1alpha promoter. These parasites are optimized for 2 photon imaging.</gtr:description><gtr:id>AFF8A7E3-28EF-4B4B-82BD-467D535AEA46</gtr:id><gtr:impact>The far red (excitation &amp;gt;1000nm) reporter parasites has enabled us to image and locate parasite deeper within tissues. The red shift of the parasites allows multiple colour imaging to visualise multiple processes/events simultaneously.</gtr:impact><gtr:outcomeId>o7FvFEDDHkA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>P. berghei ANKA TagRFP</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Transgenic P. berghei ANKA parasites were created where the fluorescent reporter mCherry was inserted into the parasite genome under the Ef-1alpha promoter</gtr:description><gtr:id>370E831B-AD37-4C64-9356-07BA684649A7</gtr:id><gtr:impact>Enabled the visualization of parasites within the brain of infected mice by two-photon microscopy</gtr:impact><gtr:outcomeId>jGXgukwJSU3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>P. berghei mCherry</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>83C30BD3-3760-44E5-B12B-963DDCFB1FB8</gtr:id><gtr:title>The subcellular location of ovalbumin in Plasmodium berghei blood stages influences the magnitude of T-cell responses.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21bbb72e73fb429ca385ad649f22bdd2"><gtr:id>21bbb72e73fb429ca385ad649f22bdd2</gtr:id><gtr:otherNames>Lin JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>546084fc0dafe0.25208114</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED9EF353-C186-48F6-8078-EC021639F075</gtr:id><gtr:title>WSX-1 signalling inhibits CD4? T cell migration to the liver during malaria infection by repressing chemokine-independent pathways.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0126cafa3c53a5ac44b4fdd1c4aa7825"><gtr:id>0126cafa3c53a5ac44b4fdd1c4aa7825</gtr:id><gtr:otherNames>Villegas-Mendez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54609e3fa57302.14808078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A41F6DB-8263-4B25-95FB-25E66E5E9966</gtr:id><gtr:title>Perivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral Malaria.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6091165703d00fb7bcdce682628c9917"><gtr:id>6091165703d00fb7bcdce682628c9917</gtr:id><gtr:otherNames>Shaw TN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56cb170d18d809.83093696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>989B53D1-F781-4FB6-89C3-A401346A4AD0</gtr:id><gtr:title>Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0126cafa3c53a5ac44b4fdd1c4aa7825"><gtr:id>0126cafa3c53a5ac44b4fdd1c4aa7825</gtr:id><gtr:otherNames>Villegas-Mendez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>5aa63fcc46e454.63744494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2881B421-F540-466A-B57B-9570188F81D0</gtr:id><gtr:title>Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0126cafa3c53a5ac44b4fdd1c4aa7825"><gtr:id>0126cafa3c53a5ac44b4fdd1c4aa7825</gtr:id><gtr:otherNames>Villegas-Mendez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>eQfKnMAXFUg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D2DD6CD-1AF0-4017-8780-A8783A253E65</gtr:id><gtr:title>IL-27 receptor signaling regulates CD4+ T cell chemotactic responses during infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dc28afd332af329245e95f98cb94c01"><gtr:id>2dc28afd332af329245e95f98cb94c01</gtr:id><gtr:otherNames>Gwyer Findlay E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_15759_29_23536628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C07C492-0DF7-499A-9BDA-195DBC00D5AC</gtr:id><gtr:title>IL-27 receptor signalling restricts the formation of pathogenic, terminally differentiated Th1 cells during malaria infection by repressing IL-12 dependent signals.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0126cafa3c53a5ac44b4fdd1c4aa7825"><gtr:id>0126cafa3c53a5ac44b4fdd1c4aa7825</gtr:id><gtr:otherNames>Villegas-Mendez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_15759_29_23593003</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D19FB8C-E3CE-48EF-ADF1-DD10AB905698</gtr:id><gtr:title>IFN-?-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0126cafa3c53a5ac44b4fdd1c4aa7825"><gtr:id>0126cafa3c53a5ac44b4fdd1c4aa7825</gtr:id><gtr:otherNames>Villegas-Mendez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_15759_29_22723523</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BFF70DE0-B78A-49BC-87F1-59EE16A2651F</gtr:id><gtr:title>A quantitative brain map of experimental cerebral malaria pathology.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be859a4f1a93f86693edfbf675b55338"><gtr:id>be859a4f1a93f86693edfbf675b55338</gtr:id><gtr:otherNames>Strangward P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a2fda5491dc73.17198047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB6A7FB7-DEDC-49E6-A07B-3A36C34C250D</gtr:id><gtr:title>Parasite-Specific CD4+ IFN-?+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0126cafa3c53a5ac44b4fdd1c4aa7825"><gtr:id>0126cafa3c53a5ac44b4fdd1c4aa7825</gtr:id><gtr:otherNames>Villegas-Mendez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>56cb170d83cbb6.93388341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01EB468D-7E47-4620-88F2-A95523C21CAA</gtr:id><gtr:title>IL-27 receptor signaling regulates memory CD4+ T cell populations and suppresses rapid inflammatory responses during secondary malaria infection.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dc28afd332af329245e95f98cb94c01"><gtr:id>2dc28afd332af329245e95f98cb94c01</gtr:id><gtr:otherNames>Gwyer Findlay E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>pm_15759_29_24101691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CBFB1ED-8F9B-4E6D-B546-10445129A99F</gtr:id><gtr:title>The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a47d952e8714470580119fcea4daf0e"><gtr:id>1a47d952e8714470580119fcea4daf0e</gtr:id><gtr:otherNames>Hafalla JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_15759_29_22319445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A6840B9-94FC-4EBB-AB3A-3E57498FBD34</gtr:id><gtr:title>IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c22e6fb93d0886d90a7f8335ccf26a0"><gtr:id>2c22e6fb93d0886d90a7f8335ccf26a0</gtr:id><gtr:otherNames>Besnard AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56cb170db31143.67587169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D4C9BF82-A2BA-4215-AA9C-DEC969B44568</gtr:id><gtr:title>Long-Lived CD4+IFN-?+ T Cells rather than Short-Lived CD4+IFN-?+IL-10+ T Cells Initiate Rapid IL-10 Production To Suppress Anamnestic T Cell Responses during Secondary Malaria Infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0126cafa3c53a5ac44b4fdd1c4aa7825"><gtr:id>0126cafa3c53a5ac44b4fdd1c4aa7825</gtr:id><gtr:otherNames>Villegas-Mendez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58b693912f74b4.14935546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B3943D4-9313-4B43-9FC9-8EB1FA138E62</gtr:id><gtr:title>Neuropathogenesis of human and murine malaria.</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99d455943e3ace8fa92cacd2133e195e"><gtr:id>99d455943e3ace8fa92cacd2133e195e</gtr:id><gtr:otherNames>Riley EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>QN3rygAeFxT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3B94ED7-1C6E-4CD5-95FF-990E1BCCF17D</gtr:id><gtr:title>Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease.</gtr:title><gtr:parentPublicationTitle>Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/428645063616f6d3fcc37a153726e878"><gtr:id>428645063616f6d3fcc37a153726e878</gtr:id><gtr:otherNames>de Souza JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0031-1820</gtr:issn><gtr:outcomeId>dpSDLP2Q8cB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900487</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>